Prognostic implications of pathogenic truncating variants in the TTN gene.

Introduction and Objectives: TTN gene truncating variants (TTNtv) are a frequent cause of dilated cardiomyopathy (DCM). However, there are discrepant data on the associated prognosis. Our objectives were to describe the prevalence of TTNtv in our cohort and to compare the clinical course with that described in the literature.
Methods: We included patients with DCM and genetic testing performed using next-generation sequencing. Through a systematic literature research, we collected information about carriers and affected relatives with TTNtv. We compared the cumulative percentage of affected carriers and the survival free of cardiovascular death.
Results: One hundred and ten DCM patients were evaluated. A total of 13 TTNtv distributed in 14 probands were identified (12.7%). We found a 21.4% prevalence in familial cases. No significant differences in the relation between age and clinical disease expression were identified. Survival free of cardiovascular death curves constructed from data in the literature seems not to overestimate the risk in our population.
Conclusions: The identification of TTNtv in patients with DCM is frequent and provides relevant information about the disease prognosis. The risk of cardiovascular death should not be underestimated. Age related penetrance need to be considered in the familial evaluation.
Competing Interests: Declaration of competing interest Drs Juan Pablo Ochoa, Marcos Cicerchia, Joel Salazar-Mendiguchia, Arsonval Lamounier, Diego Garcia-Giustiniani, Xusto Fernandez, Martin Ortiz-Genga are employees of Health in Code SL. Lorenzo Monserrat is CEO of Health in Code SL.
(Copyright © 2020 Elsevier B.V. All rights reserved.)